Thailand Tightens Regulations on GLP-1 Weight-Loss Injections

According to a report by Thai Post, the Thai Food and Drug Administration (FDA) has officially upgraded the regulatory status of GLP-1 receptor agonist injections, commonly referred to as 'weight-loss pens,' to the category of 'specially controlled drugs.' This policy change, which took effect on September 15, 2026, mandates that these medications can now only be dispensed under the direct supervision and prescription of a licensed physician.

For residents and travelers in Thailand, this update is significant as it restricts the over-the-counter availability of these products. Individuals who previously accessed these medications without a prescription will now need to consult with a medical professional to obtain them legally. This measure is intended to ensure safer usage and oversight of the drugs, which have gained popularity for weight management.

While the regulation is now in effect, several details remain to be confirmed regarding the enforcement process at pharmacies and the specific documentation required for travelers who may be carrying these medications for personal use. Visitors currently using GLP-1 injections are advised to carry a valid prescription from their doctor to avoid potential complications. As this is a recent regulatory shift, travelers should monitor local health authority announcements for further guidance on compliance and availability.